About

Igor Nunes‐Silva is a leading urologic surgeon and researcher whose work centers on advancing the surgical management of prostate cancer, with a particular focus on optimizing outcomes through robot-assisted radical prostatectomy (RARP) and focal therapy. His major contributions include pioneering comparative analyses of partial gland ablation versus radical prostatectomy for low- and intermediate-risk disease, demonstrating that focal therapy can preserve functional outcomes without compromising oncologic control. He has also systematically evaluated the role of salvage RARP after prior focal therapy, showing that while feasible, it carries distinct perioperative challenges. His meta-analyses on surgical margins and biochemical recurrence in high-risk prostate cancer, as well as the safety of continuing aspirin during RARP, have directly informed clinical guidelines. With over 200 citations across his most-cited works, Nunes‐Silva’s research has shaped modern prostate cancer surgery. Notably, he reported the first Brazilian experience with salvage Retzius-sparing RARP, a technically demanding approach that improves continence outcomes. His work consistently bridges surgical innovation with evidence-based practice, making him a key figure in the evolution of minimally invasive prostate cancer care.

Research Focus

Key Achievements

8
H-Index
13
Papers
215
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Prior Focal Therapy on Perioperative, Oncologic and Functional Outcomes of Salvage Robotic Assisted Radical Prostatectomy
52 citations · 2017
📈 Most Prolific Year: 2017 (6 Papers)
🤝 Key Collaborators: 52
🏛 Institutions: Institute Mutualiste Montsouris, Université Paris Cité, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina do ABC

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago